NCT03070509

Pharmacokinetics of Lisdexamfetamine (Vyvanse®) in Post-bariatric Surgery Patients

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: North Dakota State University · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

This study is being conducted to evaluate how the body absorbs and processes the medication lisdexamfetamine (Vyvanse®). Subjects who are 9-15 months post gastric bypass surgery will be invited to participate. Non-surgical controls will also be enrolled based on a matching criteria to post gastric bypass subjects. Participants will be asked to complete one 12-hour study day and complete one 24-hour post dosing blood draw.

Conditions

• Lisdexamfetamine

Interventions

Type	Name	Description
DRUG	Lisdexamfetamine	lisdexamfetamine 50 mg single dose

Timeline

• Start date: 2017-05-12
• Primary completion: 2019-07-01
• Completion: 2019-07-01
• First posted: 2017-03-03
• Last updated: 2018-08-23

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study